CXCL12-(1-17) [2554]



CXCL12-(1-17)


SMILES CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
InChIKey UQMATGKUTLWKOZ-DMVRXRCYSA-N
Sequence KPVSLSYRCPCRFFESH
HELM PEPTIDE1{K.P.V.S.L.S.Y.R.C.P.C.R.F.F.E.S.H}$$$$

Chemical Properties

Hydrogen bond acceptors 29
Hydrogen bond donors 29
Rotatable bonds 62
Log P -7.793
Molecular weight (Da) 2055.0
Stereochemistry info unspecified

Database connections



Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

CXCL12-(1-17)


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.